Long Read Sequencing Market Key Players and Growth Insights (2024-2034)
Long Read Sequencing Market Growth, Key Players and Future Outlook
The long read sequencing market, valued at US$ 0.6 billion in 2023, is expected to grow to US$ 11.6 billion by 2034, driven by a CAGR of 30.96%. This growth is fueled by the rising prevalence of genetic disorders, advancements in R&D, and the increasing demand for personalized medicine. Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5324Long Read Sequencing Market: The Future of DNA Sequencing
Long-read sequencing (LRS) is an advanced DNA sequencing technique that determines the nucleotide sequence of long DNA strands. Unlike short-read sequencing, which requires cutting and amplifying the DNA, LRS offers a more efficient and accurate way to sequence long stretches of DNA. This method can read tens to thousands of kilobases in length, making it especially valuable for detecting large-scale mutations, such as large deletions or rearrangements in the DNA. The growing demand for genomics research, fueled by increasing cases of genetic and chromosomal disorders, is driving the long-read sequencing market. Advances in molecular biology are also pushing the boundaries of genetic variation studies, helping to uncover mutations behind human diseases. Additionally, the rising demand for personalized medicine is further accelerating the adoption of LRS technologies.Recent Trends in the Long Read Sequencing Market
In October 2024, Azenta Inc. launched a long-read Whole Genome Sequencing (WGS) test for clinical use, becoming the first commercial provider in the US to gain regulatory approval for this service. That same month, PacBio announced a partnership with the National Cancer Center of Singapore (NCCS) to use its cutting-edge sequencing technologies to advance cancer research and map the genomic landscape of common cancers in Asia. In July 2024, Oxford Nanopore Technologies expanded its collaboration with Plasmidsaurus to revolutionize the plasmid sequencing market through innovative nanopore technology.Leading Companies in the Long Read Sequencing Market
- 10x Genomics: A leader in genomic technologies, 10x Genomics offers cutting-edge solutions for single-cell analysis and long-read sequencing. Their Chromium platform allows researchers to analyze complex genomes with high accuracy, contributing to advancements in cancer research, immunology, and genetics.
- Agilent Technologies: Agilent offers a comprehensive range of genomic sequencing tools, including platforms designed for long-read sequencing. They provide solutions for high-throughput sequencing applications, helping researchers in drug discovery, clinical research, and personalized medicine.
- Azenta Life Sciences: Azenta is known for its expertise in life sciences research, offering a variety of sequencing technologies, including long-read solutions. Their recent launch of long-read Whole Genome Sequencing (WGS) for clinical applications positions them as a key player in advancing precision medicine.
- BGI Genomics: A global leader in genomics, BGI Genomics offers long-read sequencing solutions that support a variety of applications in genetic research, agriculture, and personalized medicine. BGI's sequencing platforms are known for their high throughput and accuracy in detecting genetic variations.
- Element Biosciences: Element Biosciences specializes in providing next-gen sequencing platforms that enable highly accurate and scalable long-read sequencing. Their technology is designed to meet the growing demands of research in genomics and human health, offering cost-effective and precise solutions.
- Illumina: One of the largest names in genomic sequencing, Illumina provides a broad range of high-performance sequencing technologies, including those supporting long-read sequencing. Their platforms are widely used across clinical diagnostics, research, and precision medicine to drive breakthroughs in genomics.
- MGI: A subsidiary of BGI Group, MGI focuses on providing innovative sequencing platforms, including long-read sequencing. Their technologies are known for high throughput, precision, and scalability, helping to accelerate research in molecular biology and personalized medicine.
- Oxford Nanopore Technologies: Oxford Nanopore is renowned for its groundbreaking nanopore sequencing technology, which is ideal for long-read sequencing applications. Their portable and real-time sequencing devices are revolutionizing genomics, enabling a wide range of applications from clinical diagnostics to environmental studies.
- Pacific Biosciences (PacBio): PacBio is a pioneer in long-read sequencing technologies, with its Sequel system being a cornerstone in the market. Their PacBio platforms enable high-accuracy sequencing, which is critical for understanding complex genomes and detecting large-scale mutations.
- Qiagen: Qiagen offers a wide array of genomic solutions, including tools for long-read sequencing. Their sequencing technologies are used in a variety of applications, such as genetic research, drug discovery, and clinical diagnostics, providing high-quality insights into genetic variations.
- Quantapore, Inc.: Quantapore is focused on developing cutting-edge sequencing technologies that are specifically tailored for long-read applications. Their innovative nanopore-based sequencing platforms provide fast, accurate, and cost-effective solutions for researchers in genetics and healthcare.
- Thermo Fisher Scientific: A major player in the life sciences industry, Thermo Fisher Scientific offers a variety of genomic sequencing technologies, including solutions for long-read sequencing. Their products are widely used in research, clinical diagnostics, and drug development, supporting advancements in precision medicine and genomics.
- Universal Sequencing Technology Corporation: This company provides a range of sequencing technologies, including long-read sequencing, designed for both research and clinical applications. Their focus is on developing highly scalable and precise genomic solutions for advancing human health and personalized medicine.
FAQ's
Answer : The global automotive active health monitoring system market size was valued at US$ 1.18 billion in 2019 and expected to reach US$ 10.87 billion by 2027.
Answer : The global automotive active health monitoring system market is growing at a compound annual growth rate (CAGR) of 31.9% during the forecast period 2020 to 2027.
Answer : Automotive active health monitoring system refers to the monitoring of important signs of drivers that includes drowsiness, tiredness, and distraction. The system includes health technologies that enhance the safety level of a vehicle. Drivers suffering with chronic diseases predicted to be benefited tremendously by the use of this new technology. Further, increasing instances of common disorders for example diabetes and obesity estimated to further surge the importance of such technologies in the forthcoming years.
Answer : Increase in the chronic diseases is a prime factor that spurs the rate of road accidents and fatalities, as several drivers are detected with cardiovascular, diabetes, and renal disorders that leads to road accidents because of distraction and tiredness. Hence, the active health monitoring system in an automobile helps in the real-time monitoring of the driver’s health and activates an alarm when any kind of problem is detected. Today, rising trend for integrating health monitoring wearable devices with the driver’s seat that continuously monitors pulse rate, blood sugar level, blood pressure, and other diseases is likely to gain significant traction over the upcoming years. In the wake of same, several automotive players are pairing with the healthcare service providers to develop innovat
Answer : Europe captured the major market share in the global automotive active health monitoring system industry and expected to retain its dominance over the forecast period. The growth of the region is mainly supported by the presence of large number of market players.
Answer : Dashboard anticipated to be the highly attractive segment within the global market attributed to the incorporation of AI and machine learning features to prevent accidents.
Answer : Pulse application segment leads the global market in 2019 because of the variation in the pulse of the driver is the major cause behind an accident.
Answer : Some of the key players operating in the market are Faurecia, TATA Elxsi, Plessey Semiconductors, Acellent Technologies, Hoana Medical, Inc., LORD, Micro Strain Sensing Systems, and FLEX LTD. among others.
Get a Sample of this Report
Long Read Sequencing Market
